Copyright © 2005, European Society of Cardiology
Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window
aMolecular and Vascular Biology and Center for Transgene Technology and Gene Therapy, University of Leuven, Belgium
bExperimental and Molecular Cardiology/CARIM, University of Maastricht, Netherlands
* Corresponding author. Experimental and Molecular Cardiology Laboratory/CARIM, Department of Cardiology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Tel.: +31 43 3882950; fax: +31 43 3871055. Email address: s.heymans{at}cardio.unimaas.nl
The post-myocardial infarction wound repair process involves temporarily overlapping phases that include inflammation, formation of granulation tissue, scar formation, and overall left ventricle (LV) remodelling. The myocardial extracellular matrix (ECM) plays an important role in maintaining the structural and functional integrity of the heart and is centrally involved in wound repair post-myocardial infarction (MI). The main proteolytic system involved in the degradation of the ECM in the heart is the matrix metalloproteinase (MMPs) system. The present review will focus on the importance of the unique temporal and spatial window of MMPs and their inhibitors (TIMPs) within the different wound healing phases post-MI. It summarizes (1) the MMP/TIMP levels at different time points post-MI, (2) the alterations seen in post-MI healing in genetically modified mice, and (3) the effects and limitations of therapeutic MMP-inhibition post-MI.
KEYWORDS Infarction; Matrix metalloproteinases (MMPs); Extracellular matrix; Remodelling; Transgenic animal models
Time for primary review 18 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. M. Winter, A. A.M. van Oorschot, B. Hogers, L. M. van der Graaf, P. A. Doevendans, R. E. Poelmann, D. E. Atsma, A. C. Gittenberger-de Groot, and M. J. Goumans A New Direction for Cardiac Regeneration Therapy: Application of Synergistically Acting Epicardium-Derived Cells and Cardiomyocyte Progenitor Cells Circ Heart Fail, November 1, 2009; 2(6): 643 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Dixon, R. C. Gorman, R. E. Stroud, S. Bouges, H. Hirotsugu, J. H. Gorman III, T. P. Martens, S. Itescu, M. D. Schuster, T. Plappert, et al. Mesenchymal Cell Transplantation and Myocardial Remodeling After Myocardial Infarction Circulation, September 15, 2009; 120(11_suppl_1): S220 - S229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Boudoulas and A. K. Hatzopoulos Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease Dis. Model. Mech., July 1, 2009; 2(7-8): 344 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Gonzalez, I. M. Seropian, M. L. Krieger, J. Palleiro, M. A. Lopez Verrilli, M. M. Gironacci, S. Cavallero, L. Wilensky, V. H. Tomasi, R. J. Gelpi, et al. Effect of early versus late AT1 receptor blockade with losartan on postmyocardial infarction ventricular remodeling in rabbits Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H375 - H386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Haghikia and D. Hilfiker-Kleiner MiRNA-21: a key to controlling the cardiac fibroblast compartment? Cardiovasc Res, April 1, 2009; 82(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
M. Hori and K. Nishida Oxidative stress and left ventricular remodelling after myocardial infarction Cardiovasc Res, February 15, 2009; 81(3): 457 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Heymans, E. Hirsch, S. D. Anker, P. Aukrust, J.-L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, February 1, 2009; 11(2): 119 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Cheng, L. Ou, Y. Liu, X. Liu, F. Li, B. Sun, Y. Che, D. Kong, Y. Yu, and G. Steinhoff Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion Cardiovasc Res, December 1, 2008; 80(3): 425 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. M. Pinto and S. Heymans Letter by Pinto and Heymans Regarding Article, "Ablation of Matrix Metalloproteinase-9 Increases Severity of Viral Myocarditis in Mice" Circulation, November 11, 2008; 118(20): e697 - e697. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Zavadzkas, R. A. Plyler, S. Bouges, C. N. Koval, W. T. Rivers, C. U. Beck, E. I. Chang, R. E. Stroud, R. Mukherjee, and F. G. Spinale Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1394 - H1402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bujak, M. Dobaczewski, K. Chatila, L. H. Mendoza, N. Li, A. Reddy, and N. G. Frangogiannis Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling Am. J. Pathol., July 1, 2008; 173(1): 57 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Jacquemet and C. S. Henriquez Loading effect of fibroblast-myocyte coupling on resting potential, impulse propagation, and repolarization: insights from a microstructure model Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2040 - H2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, Y. Ma, W. Han, J. Li, Y. Xiang, F. Liu, X. Ma, J. Zhang, Z. Fu, Y.-D. Su, et al. Age-related differences in postinfarct left ventricular rupture and remodeling Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1815 - H1822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Castardeli, D. R. Duarte, M. F. Minicucci, P. S. Azevedo, B. B. Matsubara, L. S. Matsubara, A. O. Campana, S. A.R. Paiva, and L. A.M. Zornoff Tobacco smoke-induced left ventricular remodelling is not associated with metalloproteinase-2 or -9 activation Eur J Heart Fail, November 1, 2007; 9(11): 1081 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Aupperle, J. Garbade, A. Schubert, M. Barten, S. Dhein, H.-A Schoon, and F.-W Mohr Effects of Autologous Stem Cells on Immunohistochemical Patterns and Gene Expression of Metalloproteinases and Their Tissue Inhibitors in Doxorubicin Cardiomyopathy in a Rabbit Model Vet. Pathol., July 1, 2007; 44(4): 494 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Agostoni and C. Banfi Matrix metalloproteinase and heart failure: is it time to move from research to clinical laboratories? Eur. Heart J., March 8, 2007; (2007) ehl574v1. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Frantz, K. Hu, B. Bayer, S. Gerondakis, J. Strotmann, A. Adamek, G. Ertl, and J. Bauersachs Absence of NF-{kappa}B subunit p50 improves heart failure after myocardial infarction FASEB J, September 1, 2006; 20(11): 1918 - 1920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Newby, M. Pauschinger, and F. G. Spinale From tadpole tails to transgenic mice: Metalloproteinases have brought about a metamorphosis in our understanding of cardiovascular disease Cardiovasc Res, February 15, 2006; 69(3): 559 - 561. [Full Text] [PDF]
|
|